Evidence map›Paper›PMID 41517535›Full record

ArticleJournal of clinical medicine2025

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.

Hermina Sánta, Laura Regáli, László Váróczy, Virág Szita, Ádám Wiedemann, Lóránt Varju, László Rejtő, Norbert Sándor Bartha, Dorottya Máté, András Masszi and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Hermina Sánta3rd Department of Internal Medicine, Hematology Fejér County University Hospital, 8000 Székesfehérvár, Hungary.ORCID 0009-0006-4319-0782
Laura RegáliNational Institute for Haematology and Infectious Diseases, South-Pest Central Hospital, 1097 Budapest, Hungary.
László VáróczyDepartment of Hematology, Institute for Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Virág SzitaDepartment of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.ORCID 0009-0005-4745-1911
Ádám WiedemannDepartment of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.
Lóránt VarjuDepartment of Hematology, Szabolcs-Szatmár-Bereg County Hospital, 4400 Nyíregyháza, Hungary.
László RejtőDepartment of Hematology, Szabolcs-Szatmár-Bereg County Hospital, 4400 Nyíregyháza, Hungary.
Norbert Sándor BarthaDepartment of Hematology, Szabolcs-Szatmár-Bereg County Hospital, 4400 Nyíregyháza, Hungary.
Dorottya MátéDepartment of Hematology, National Institute of Oncology, 1122 Budapest, Hungary.
András MassziDepartment of Hematology, National Institute of Oncology, 1122 Budapest, Hungary.
Márk PlanderDepartment of Hematology and Hemostaseology, Vas County Markusovszky University Hospital, 9700 Szombathely, Hungary.
Szabolcs KosztolányiFirst Department of Internal Medicine, University of Pécs-Clinical Centre, 7624 Pécs, Hungary.
Alizadeh HussainFirst Department of Internal Medicine, University of Pécs-Clinical Centre, 7624 Pécs, Hungary.
Piroska PettendiDepartment of Hematology, Jász-Nagykun-Szolnok County Géza Hetényi Hospital, 5000 Szolnok, Hungary.
Ildikó IstenesDepartment of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary.
Árpád Szomor3rd Department of Internal Medicine, Hematology Fejér County University Hospital, 8000 Székesfehérvár, Hungary.
Péter ReményiNational Institute for Haematology and Infectious Diseases, South-Pest Central Hospital, 1097 Budapest, Hungary.
Tamás MassziDepartment of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.ORCID 0000-0003-2322-9863
Gergely VargaDepartment of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.ORCID 0000-0001-6875-056X
Gábor MikalaDepartment of Internal Medicine and Hematology, Semmelweis University, 1088 Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biochemical progressionixazomibmultiple myelomarelapsed

Identifiers

PMID41517535
PMCPMC12786464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.